Archives20242023202220212020201920182017201620152014201320122011ImmuPharma’s CEO, Tim McCarthy, talks to Proactive Investor and presents the commercial strategy for the Company’s lupus drug Lupuzor™ as FDA approves PK study in advance to starting the Phase 3 trial – 17th August, 2021 17th August 2021 - 3:48 pmShare this article Share on Facebook Share on Twitter
ImmuPharma’s CEO, Tim McCarthy, talks to Proactive Investor and presents the commercial strategy for the Company’s lupus drug Lupuzor™ as FDA approves PK study in advance to starting the Phase 3 trial – 17th August, 2021 17th August 2021 - 3:48 pm
